Double Blind Atorvastatin Amlodipine Study

NCT00159718 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

360

Enrollment

INDUSTRY

Sponsor class

Conditions

Angina

Interventions

DRUG: amlodipine
DRUG: atorvastatin

Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.